Markets:

Overview

News

Currencies

International

Treasuries

Longeveron Inc. - Class A Common stock (NQ:LGVN)

0.5626 +0.0026 (+0.46%)

Streaming Delayed Price Updated: 11:07 AM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Longeveron Inc. - Class A Common stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

5 Stocks To Watch For April 6, 2022 ↗

April 06, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects RPM International Inc. (NYSE: RPM) to report quarterly earnings at $0.30 per share on revenue of $1.41 million before the...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 05, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 141.5% to $5.46 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 114.7...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 05, 2022

Good morning, investor! It's time to start off another busy day of trading with the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 04, 2022

Gainers Cognition Therapeutics (NASDAQ:CGTX) shares increased by 26.2% to $3.28 during Monday's regular session. Trading volume for Cognition Therapeutics's stock...

Via Benzinga

68 Biggest Movers From Yesterday ↗

April 05, 2022

Gainers GBS Inc. (NASDAQ: GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation. Aterian, Inc. (NASDAQ: ATER) shares...

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

April 04, 2022

Gainers Aterian, Inc. (NASDAQ: ATER) shares jumped 43.5% to $3.3457. Aterian said Cynthia Williams has joined the Company's Board of Directors. Jumia Technologies AG (...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 04, 2022

Via Benzinga

The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight ↗

April 03, 2022

Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 01, 2022

Gainers Yumanity Therapeutics (NASDAQ:YMTX) shares rose 13.3% to $1.7 during Friday's pre-market session. The market value of their outstanding shares is at $18.4...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

April 01, 2022

Good morning, investor! It's the last trading day of the week and that means it's time to get into the pre-market stock movers for Friday!

Via InvestorPlace

21 Stocks Moving in Friday's Pre-Market Session ↗

April 01, 2022

Gainers Blackboxstocks Inc. (NASDAQ: BLBX) rose 37.6% to $3.69 in pre-market trading after the company reported better-than-expected Q4 sales results. Chicken Soup for the Soul...

Via Benzinga

53 Biggest Movers From Yesterday ↗

April 01, 2022

Gainers Longeveron Inc. (NASDAQ: LGVN) shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 180 Points; Creative Medical Technology Shares Spike Higher ↗

March 31, 2022

U.S. stocks traded lower toward the end of trading following the release of weekly jobless claims data. The Dow traded down 0.52% to 35,043.99 while the NASDAQ fell 0.22% to 14,...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 31, 2022

Gainers Longeveron (NASDAQ:LGVN) stock rose 60.6% to $10.79 during Thursday's regular session. As of 13:31 EST, this security is trading at a volume of 84.1 million...

Via Benzinga

36 Stocks Moving In Thursday's Mid-Day Session ↗

March 31, 2022

Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 71% to $11.57 after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with...

Via Benzinga

Is NIO Stock a Buy? What the Bulls and Bears Are Saying. ↗

March 31, 2022

Nio (NIO) stock is sliding lower on Thursday after rallying earlier this week and that has some investors wondering if the stock is a buy.

Via InvestorPlace

Alzheimer’s News: Why Is Drugmaker Longeveron (LGVN) Soaring Today? ↗

March 31, 2022

Longeveron (LGVN) stock is taking off on Thursday after the drugmaker published news related to an Alzheimer's treatment.

Via InvestorPlace

Mid-Day Market Update: Crude Oil Down Over 3%; RCM Technologies Shares Jump ↗

March 31, 2022

U.S. stocks traded lower midway through trading following the release of weekly jobless claims data.

Via Benzinga

Analyzing Longeveron Inc. - common stock's Short Interest ↗

March 31, 2022

Longeveron Inc. - common stock's (NASDAQ:LGVN) short percent of float has fallen 10.14% since its last report. The company recently reported that it has 412.90 thousand shares...

Via Benzinga

Mid-Morning Market Update: US Markets Open Lower As Initial Jobless Claims Rise ↗

March 31, 2022

U.S. stocks opened on a weak note this morning following the release of weekly jobless claims data.

Via Benzinga

Why Longeveron Shares Are Surging Today ↗

March 31, 2022

Longeveron Inc (NASDAQ: LGVN) shares are trading higher Thursday after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients...

Via Benzinga

R&D Efforts for Alzheimer’s Therapies on the Rise with over 120 Drugs in Development

March 31, 2022

Palm Beach, FL – March 31, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is an irreversible, progressive neurodegenerative disease. It is the most common cause of dementia...

Via FinancialNewsMedia

EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal ↗

March 31, 2022

Longeveron Inc (NASDAQ: LGVN) announced the publication of Phase 1 trial results of Lomecel-B on patients with mild Alzheimer's disease (AD) in the Alzheimer's & Dementia journal.

Via Benzinga

Healthspan, Not Lifespan Should Be the Focus of Anti-Aging Research, Says Longeveron ↗

March 30, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022 ↗

March 24, 2022

Upgrades For iRobot Corp (NASDAQ:IRBT), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. In the fourth quarter, iRobot showed an EPS of $1....

Via Benzinga

5 Cheap Energy Stocks Riding Oil Higher ↗

March 23, 2022

Energy is understandably at the top of every investor's mind right now, but finding the best energy stocks requires careful consideration.

Via InvestorPlace

My No. 2 Stock Pick For 2022 Rises 100%… ↗

March 15, 2022

There isn't just one kind of good stock, and there isn't just one good strategy for when to sell. You need a variety of approaches.

Via InvestorPlace

Longeveron Announces Fourth Quarter And Full Year 2021 Financial Results And Operational Progress ↗

March 14, 2022

Currently Enrolling Clinical Trials with Lomecel-B in Three Disease Indications: Hypoplastic Left Heart Syndrome (Phase 2a), Alzheimer’s Disease (Phase 2a), and Covid-...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 11, 2022

Gainers CVRx (NASDAQ:CVRX) shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outstanding shares is at $156.2 million.

Via Benzinga

Earnings Scheduled For March 11, 2022 ↗

March 11, 2022

Companies Reporting Before The Bell • The Real Good Food (NASDAQ:RGF) is estimated to report quarterly loss at $0.19 per share on revenue of $25.29 million. •...

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Longeveron Inc. - Class A Common stock (NQ:LGVN)

All News about Longeveron Inc. - Class A Common stock

Starting at $3.75/week.

Subscribe Today